Page 119 - Read Online

Page 12 of 14 Obeid et al. Vessel Plus 2022;6:43 https://dx.doi.org/10.20517/2574-1209.2021.136

REFERENCES
1. Skanes AC, Tang ASL. Atrial fibrillation and heart failure: untangling a modern gordian knot. Can J Cardiol 2018;34:1437-48. DOI
PubMed
2. Boyle NG, Shivkumar K. Atrial fibrillation in congestive heart failure: current management. Cardiol Clin 2009;27:79-93. DOI
PubMed
3. Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. The
American Journal of Cardiology 2003;91:2-8. DOI PubMed
4. Carlisle MA, Fudim M, DeVore AD, Piccini JP. Heart Failure and atrial fibrillation, like fire and fury. JACC Heart Fail 2019;7:447-
56. DOI PubMed
5. Colvin M, Smith JM, Ahn Y, et al. OPTN/SRTR 2019 annual data report: heart. Am J Transplant 2021;21 Suppl 2:356-440. DOI
PubMed
6. Rose EA, Gelijns AC, Moskowitz AJ, et al. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart
Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med
2001;345:1435-43. DOI PubMed
7. Lietz K, Long JW, Kfoury AG, et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-
REMATCH era: implications for patient selection. Circulation 2007;116:497-505. DOI PubMed
8. Long JW, Kfoury AG, Slaughter MS, et al. Long-term destination therapy with the HeartMate XVE left ventricular assist device:
improved outcomes since the REMATCH study. Congest Heart Fail 2005;11:133-8. DOI PubMed
9. Hamed S, Schmack B, Mueller F, et al. Implementation of an intensified outpatient follow-up protocol improves outcomes in patients
with ventricular assist devices. Clin Res Cardiol 2019;108:1197-207. DOI PubMed
10. Hanke JS, Dogan G, Zoch A, et al. One-year outcomes with the HeartMate 3 left ventricular assist device. J Thorac Cardiovasc Surg
2018;156:662-9. DOI PubMed
11. Chakaramakkil MJ, Sivathasan C. ECMO and short-term support for cardiogenic shock in heart failure. Curr Cardiol Rep 2018;20:87.
DOI PubMed
12. Richardson AS, Schmidt M, Bailey M, Pellegrino VA, Rycus PT, Pilcher DV. ECMO Cardio-Pulmonary Resuscitation (ECPR), trends
in survival from an international multicentre cohort study over 12-years. Resuscitation 2017;112:34-40. DOI PubMed
13. Yang JH, Choi KH, Ko YG, et al. Clinical characteristics and predictors of in-hospital mortality in patients with cardiogenic shock:
results from the RESCUE registry. Circ Heart Fail 2021;14:e008141. DOI PubMed
14. Enriquez AD, Calenda B, Gandhi PU, Nair AP, Anyanwu AC, Pinney SP. Clinical impact of atrial fibrillation in patients with the
HeartMate II left ventricular assist device. J Am Coll Cardiol 2014;64:1883-90. DOI PubMed
15. Stulak JM, Deo S, Schirger J, et al. Preoperative atrial fibrillation increases risk of thromboembolic events after left ventricular assist
device implantation. Ann Thorac Surg 2013;96:2161-7. DOI PubMed
16. Hickey KT, Garan H, Mancini DM, et al. Atrial fibrillation in patients with left ventricular assist devices: incidence, predictors, and
clinical outcomes. JACC Clin Electrophysiol 2016;2:793-8. DOI PubMed
17. Deshmukh A, Kim G, Burke M, et al. Atrial arrhythmias and electroanatomical remodeling in patients with left ventricular assist
devices. J Am Heart Assoc 2017;6:e005340. DOI PubMed PMC
18. Colombo PC, Mehra MR, Goldstein DJ, et al. Comprehensive analysis of stroke in the long-term cohort of the MOMENTUM 3 Study.
Circulation 2019;139:155-68. DOI PubMed
19. Cho SM, Starling RC, Teuteberg J, et al. Understanding risk factors and predictors for stroke subtypes in the ENDURANCE trials. J
Heart Lung Transplant 2020;39:639-47. DOI PubMed
20. Chiang YP, Cox D, Schroder JN, et al. Stroke risk following implantation of current generation centrifugal flow left ventricular assist
devices. J Card Surg 2020;35:383-9. DOI PubMed
21. Galand V, Flécher E, Auffret V, et al. Early ventricular arrhythmias after lvad implantation is the strongest predictor of 30-day post-
operative mortality. JACC Clin Electrophysiol 2019;5:944-54. DOI PubMed
22. Blumer V, Ortiz Bezara M, Kittipibul V, et al. Impact of atrial fibrillation on in-hospital mortality and thromboembolic complications
after left ventricular assist device implantation. J Cardiovasc Transl Res 2021;14:120-4. DOI PubMed
23. Tahsili-Fahadan P, Curfman DR, Davis AA, et al. Cerebrovascular events after continuous-flow left ventricular assist devices.
Neurocrit Care 2018;29:225-32. DOI PubMed
24. Parikh NS, Cool J, Karas MG, Boehme AK, Kamel H. Stroke risk and mortality in patients with ventricular assist devices. Stroke
2016;47:2702-6. DOI PubMed PMC
25. Sherazi S, Kouides P, Francis C, et al. Prospective analysis of bleeding events in left ventricular assist device patients. Int J Artif
Organs 2018;41:269-76. DOI PubMed
26. Papathanasiou M, Mincu RI, Lortz J, et al. Prolonged mechanical ventilation after left ventricular assist device implantation: risk
factors and clinical implications. ESC Heart Fail 2019;6:545-51. DOI PubMed PMC
27. Hickey KT, Colombo PC, Naka Y, et al. Atrial fibrillation is associated with recurrent ventricular arrhythmias after lvad implant:
incidence and impact in a consecutive series. J Cardiovasc Transl Res 2020;13:199-203. DOI PubMed
28. Brenyo A, Rao M, Koneru S, et al. Risk of mortality for ventricular arrhythmia in ambulatory LVAD patients. J Cardiovasc
Electrophysiol 2012;23:515-20. DOI PubMed
29. Iwasaki K, Seguchi O, Murata S, et al. Effect of the creatinine excretion rate index, a marker of sarcopenia, on prediction of